A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population

Not yet recruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

June 1, 2026

Primary Completion Date

January 1, 2031

Study Completion Date

June 1, 2032

Conditions
Hypertrophic Cardiomyopathy (HCM)
Interventions
OTHER

No interventions were applied to the patients.

No interventions were applied to the patients.

Trial Locations (1)

310009

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER